logo
Wyoming lawmakers consider addressing health insurance fraud concern by Blue Cross

Wyoming lawmakers consider addressing health insurance fraud concern by Blue Cross

Yahoo24-05-2025

CHEYENNE — The state's ability to curb a spike in fraudulent health care filings under Blue Cross Blue Shield of Wyoming is limited, but lawmakers agreed Thursday to do what they can to navigate this issue in their respective committees.
An 'unusual uptick' in Native American health care enrollment set off alarm bells at Blue Cross Blue Shield of Wyoming (BCBSWY). As of March 2025, Native American enrollment in BCBSWY health care plans on the federal marketplace is up 500%, and Native American claims are up by more than 1,000%.
Overall, mental health and substance abuse disorder claims have increased over 300% in 2025.
Investigators suspect Wyoming is the latest target in a nationwide health care scam of illegal claim filings. 'Body brokers' are scouting out homeless shelters to find victims and ship them to out-of-state facilities, where the insurance company is then billed for substance abuse treatment that is not actually being provided.
Stories collected by BCBSWY found that Wyoming victims are showing up in these fraudulent treatment centers, most of them in California, with others in Arizona and Florida. Furthermore, an internal investigation found many health insurance enrollees are not legitimate Wyoming residents.
Out of more than 1,500 potentially fraudulent enrollees identified in Native and non-Native federal health care plans, less than 40 have been confirmed as legitimate, according to a BCBSWY news release.
BCBSWY representatives raised this issue before state lawmakers during the Legislature's Select Committee on Tribal Relations meeting in Fort Washakie. Co-Chairman Sen. Cale Case, R-Lander, found the situation alarming, and asked how the state can help.
'Awareness is the main reason that we're here today,' said BCBSWY Government Affairs Principal and Privacy Officer Kelsey Prestesater. 'We want to get this news out to as many people as we possibly can, and encourage individuals if they feel like they have fallen victim to this, or know somebody who has, to certainly reach out.'
Potential state solutions
Prestesater offered a few remedies for state lawmakers to pursue. One solution is to draft a bill that requires stronger oversight of licensing requirements for in-state behavioral health and substance abuse treatment facilities.
'Currently, there are virtually no regulations for these types of residential treatment centers,' Prestesater said. 'While these treatment centers are not here now, we've seen a pattern where these treatment centers move from state to state, where they can find the least amount of regulation and begin to victimize those people.'
She also suggested revisiting a bill that was filed in the recent legislative session by the Joint Corporations, Elections and Political Subdivisions Committee, but failed to be introduced. House Bill 71, 'Insurance fraud reporting,' would have required insurers to report suspected and known fraud.
'That would really help us and give us some teeth in being able to report these bad actors and provide a shield from civil liability,' Prestesater said.
Case, who is also co-chairman of the Joint Corporations Committee, said he will bring up HB 71 at the committee's next meeting for consideration. He told the WTE in a phone call after the meeting 'there's more of an urgency now with the story out there.'
But it's ultimately up to the committee, he said.
Sen. Eric Barlow, R-Gillette, who co-chairs the Joint Labor, Health and Social Services Committee, said he will speak with his co-chair about studying professional licensing requirements as an additional interim topic for the committee.
BCBSWY Vice President of Legal Services Rocky Redd suggested a third option, which is to allow a pause in claim payments to fraudulent actors if the insurance company finds credible evidence of fraud.
In Wyoming, the insurance company has 45 days to sift through thousands of pages of records before making a claims payment.
'Some of the other states have … passed legislation that would allow you to pause that, to take a little bit more time to look into it before you have to go ahead and pay them,' Redd said. Otherwise, Blue Cross risks getting sued for not making the payment by deadline.
A federal government issue
Since Native American health insurance is regulated only at the federal level, there is little action the state can take on this issue, Deputy Commissioner Tana Howard at the Wyoming Department of Insurance told the Wyoming Tribune Eagle earlier this week.
'The solution needs to come from the feds. It needs to come from (the Centers of Medicare & Medicaid Services), since they are the ones who regulate these plans,' Howard said.
From her understanding, Blue Cross cannot deny claims in question under federal law, as these are federally regulated plans. Howard said she was recently informed that the case was forwarded by CMS to the Center for Program Integrity, an internal division of CMS that detects fraud, waste and abuse.
North Dakota has reported a similar issue in health insurance fraud with its own Blue Cross insurance company, Howard added. The northern state implemented a waiver program in response that requires insured members to justify out-of-state health care.
But this isn't a solution that would fit in Wyoming, she said.
'North Dakota is completely different than Wyoming. They have a lot more providers. They have a lot more hospital systems,' Howard said. 'There are not very many facilities in Wyoming that really offer (substance abuse treatment). And so it's not uncommon for it to go out of state.'
A similar situation
Cowboy State Daily reported a 'mysterious' incident in 2023, where a dozen unhoused individuals were taken from Fremont County and dropped off at a homeless shelter in Casper.
Northern Arapaho Business Council Co-Chairwoman Kimberly Whiteman Harjo reminded lawmakers of this situation during Thursday's meeting. She told committee members the scheme described by Blue Cross representatives reminded her of that incident.
'There are places in Riverton that will say that they help homeless people, but I don't know what their rules are, the procedures,' Harjo said. 'But a lot of our people were put out in the freezing cold during the wintertime, and it was at night.'
The Wind River Indian Reservation is a constant target of fraudulent companies, she said. Case recalled the incident when he later spoke with the WTE. The committee co-chairman said he was disappointed the 'kidnapping,' as he referred to it, was not taken more seriously by local entities.
Authorities never discovered who was behind taking people and dropping them off at the Casper shelter, he said.
'People were rounded up, given promises (for treatment),' Case said. 'And they were taken to Casper and kind of dumped off, and that just made me really angry.'
A Blue Cross spokesperson confirmed to the WTE this situation is not related to the health care insurance fraud reported by the insurance company.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Botulism cases linked to Botox injections under investigation in Massachusetts
Botulism cases linked to Botox injections under investigation in Massachusetts

Yahoo

time10 hours ago

  • Yahoo

Botulism cases linked to Botox injections under investigation in Massachusetts

Massachusetts health officials are investigating four recent cases of suspected botulism connected to cosmetic injections of Botox. The outbreak on the South Shore prompted the Department of Public Health to warn health care providers to be alert about symptoms. consistent with botulism occurring after botulinum toxin injections. Botox is widely used for cosmetic purposes to reduce wrinkles and fine lines. 'While generally safe when administered by trained professionals, improper dosing, administration technique, or use of non-FDA-approved products may increase the risk of systemic botulism symptoms,' the DPH advisory said. Botulism, though rare, can be fatal. It occurs when botulinum toxin enters the bloodstream and can produce effects far from the injection site, according to the advisory. Initial botulism symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing and breathing problems, according to state health officials. These symptoms may progress to muscle weakness that worsens over hours to days. Anybody who is experiencing any symptoms should go to an emergency room. 'This is very rare,' South Shore Hospital infectious disease specialist Dr. Todd Ellerin told WCVB. 'We call it iatrogenic botulism, which means you get it as a complication of an injection. It is very rare.' The DPH has not released details about the condition of the four individuals involved in the South Shore cases or information about the provider or facility where they received their injections. How pink heart shaped fentanyl led to Mass. father's 18-year prison sentence ICE deportation blocked by Boston judge: Migrants now in shipping container in Djibouti Mass. State Lottery winner: Father will take children to Disney with $100K prize Former police deputy chief, school resource officer convicted of child rape Mass. casino winner: $2.50 bet won gambler jackpot prize ``` Read the original article on MassLive.

Texas bill allocates $13M for animal spay and neutering services
Texas bill allocates $13M for animal spay and neutering services

Yahoo

timea day ago

  • Yahoo

Texas bill allocates $13M for animal spay and neutering services

The Brief The budget passed by the Texas Legislature allocates $13 million to a pilot program to spay and neuter cats and dogs. Gov. Greg Abbott has yet to approve this funding. This builds off of recently passed legislation, Senate Bill 1568, which created specialty license plates to fund animal sterilization. Texas lawmakers passed a budget that sets aside $13 million for animal spaying and neutering services in order to limit the spread of infectious diseases. If approved by the governor, the Department of State Health Services (DSHS) would lead a statewide pilot program over the next two years. What we know The program was created in an effort to reduce the prevalence of infectious diseases such as rabies, toxoplasmosis, and leptospirosis. These diseases, which can be transferred from animals to humans, can cause adverse side effects in people. What they're saying Shelby Bobosky, executive director of the Texas Humane Legislation Network (TLHN), said the pilot program is a crucial step forward in protecting both animals and people. "Shelters, veterinarians, and local communities have long struggled with limited resources to manage stray and feral animal populations," she said. "This funding is not only indispensable, but it also reflects a clear understanding by the Legislature that animal welfare is a vital part of our public health infrastructure." Bobosky believes the effort will help to tackle Texas' pet overpopulation problem while working to improve community health. The backstory The pilot program is a continuation of previous legislation the TLHN led: Senate Bill 1568, which passed on May 24, 2025. This bill, authored by State Senator Judith Zaffirini, a Democrat from South Texas, created specialty license plates to promote public participation in animal sterilization. The new license plates would include the phrase "Spray. Neuter. Adopt." The sales of this license plate would support the Animal Friendly Account to help fund programs and organizations that support animal sterilization in order to reduce stray populations. What's next If signed into law by Gov. Greg Abbott, the DSHS will begin forming the plans and procedures to implement the pilot program over the upcoming months. The TLHN plans to work with animal shelters, veterinary professionals, rescue organizations, and local municipalities to collect feedback to share with the DSHS. The Source This information was gathered from Texas Policy Research, as well as a news release sent by the Texas Humane Legislation Network.

Pharmaceutical company AstraZeneca sues to stop Utah law expanding access to discounted drugs
Pharmaceutical company AstraZeneca sues to stop Utah law expanding access to discounted drugs

Yahoo

time2 days ago

  • Yahoo

Pharmaceutical company AstraZeneca sues to stop Utah law expanding access to discounted drugs

Sen. Evan Vickers, R-Cedar City, is pictured on the first day of the legislative session at the Capitol in Salt Lake City on Tuesday, Jan. 16, 2024. (Photo by Spenser Heaps for Utah News Dispatch) Pharmaceutical giant AstraZeneca is suing Utah's attorney general and insurance commissioner over a law passed during the legislative session aimed at stopping drug manufacturers from limiting where hospitals and clinics can buy discounted medication. Filed in May in federal court in the District of Utah, the company accuses the law of being unconstitutional and in conflict with prior court rulings. Sponsored by Sen. Evan Vickers, R-Cedar City, SB69 deals with the federal 340B program, a decadesold provision in the Public Health Service Act that aims to supply hospitals and health clinics with drugs at a discounted price. The program requires drug manufacturers to provide discounts on certain outpatient drugs for entities covered under the program, like hospitals, clinics, or Native American tribes. According to the American Hospital Association, hospitals can pass savings from the 340B program along to patients by offering health care to uninsured patients, providing free vaccinations, or expanding mental and community health programs. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX But Vickers, who owns and operates a pharmacy in Cedar City, said the program is not popular among drug manufacturers, who have tried to limit where the entities covered under 340B can obtain the discounted drugs. Speaking on the Senate floor earlier this year, Vickers said manufacturers have been enforcing a 'one pharmacy rule,' where certain drugs can only be obtained from certain pharmacies. 'From their perspective it's expanded more than they would like, so they've tried to limit the access of drugs,' Vickers said. 'Essentially, you could have a patient being able to get a product at a discounted price in one town but not the other.' SB69, which passed in March during the final week of the legislative session, tries to prevent this. The bill is relatively simple at just 53 lines, and states that drug manufacturers cannot restrict pharmacies from contracting with entities covered under the 340B program. It also restricts manufacturers from preventing the delivery of a 340B drug to any location authorized to receive it. 'I don't stand here professing that the manufacturers are happy with this, I will tell you they're not,' said Vickers earlier this year, telling his Senate colleagues that states that have passed similar legislation have been targeted by lawsuits. 'But what we're looking at is providing access to medication at a discounted price.' Vickers was right. AstraZeneca, the global pharmaceutical company that generated more than $54 billion in revenue in 2024, is now suing Utah Attorney General Derek Brown and Utah Insurance Commissioner Jon Pike to stop the enforcement of SB69. The Utah Attorney General's Office did not provide comment on the active litigation. In the complaint, attorneys for AstraZeneca point to prior court rulings that supersede Utah's law. 'Apparently dissatisfied with the scope of federal law, the State of Utah has enacted a statute seeking to achieve under state law precisely the same result that federal courts have resoundingly rejected,' the complaint reads, accusing SB69 of requiring 'discounted pricing for sales at an unlimited number of contract pharmacies.' According to AstraZeneca, the requirement in SB69 goes beyond the original intent of the 340B program, putting state law at odds with federal law and violating the Supremacy Clause of the U.S. Constitution. Plus, the lawsuit alleges, SB69 violates the Contracts Clause of the Constitution because it interferes with agreements between drug manufacturers and the U.S. Department of Health and Human Services, as well as the Constitution's Takings Clause, which protects private property from being seized for public use, since SB69 requires AstraZeneca to transfer its private property (prescription drugs) to entities covered under 340B. SUPPORT: YOU MAKE OUR WORK POSSIBLE

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store